Judy

Automation in medical device assembly is transforming how MedTech manufacturers achieve near‑zero defect rates. By integrating AI, robotics, and sensor‑driven “smart factories,” companies can standardize assembly, detect anomalies in real time, and maintain continuous process improvement. For procurement teams, this means auditing a manufacturer’s assembly automation is now a prerequisite for long‑term, zero‑defect sourcing strategies. […]

Medical device shortages in 2026—especially in products like stereotactic breast biopsy needles and dialysis bloodlines—are expected to persist into Q4, disrupting surgical schedules and dialysis care. By diversifying vendors, monitoring the FDA medical device shortage list, and leveraging digital‑first procurement platforms such as HHG GROUP, health systems can build supply‑chain resilience and reduce OR‑level disruptions.

Medical device development progresses through defined stages including concept validation, structured design under ISO 13485, preclinical testing, regulatory approval, clinical trials, and commercialization. Each phase ensures safety, performance, and compliance. By integrating engineering, clinical evidence, and regulatory strategy, innovators successfully transform prototypes into market-ready solutions that improve patient outcomes and meet global healthcare standards. What

The top 10 medical device companies in 2026 by revenue and innovation include Medtronic ($33.5B), Johnson & Johnson MedTech ($31.9B), Medline Industries ($25.5B), Siemens Healthineers ($24.2B), Stryker ($22.6B), GE HealthCare ($19.7B), Royal Philips ($19.5B), Abbott ($19.0B), Boston Scientific ($16.7B), and BD ($15.1B), focusing on robotics, AI, and remote monitoring. What Are the Top Medical Device

Shockwave therapy and TenJet both effectively treat chronic tendon pain like tennis elbow and Achilles tendinitis. Shockwave uses acoustic waves to stimulate healing non-invasively, ideal for broad tissue regeneration. TenJet employs a precise saline jet to remove diseased tissue, suiting targeted cases. Choice depends on severity, with TenJet offering faster recovery but higher initial costs.

The MFDS has introduced streamlined guidelines to help medical‑device manufacturers in South Korea respond faster to raw‑material shortages. These measures allow accelerated approvals, simplified documentation, and targeted government support for producers of essential devices and consumables, giving international firms that source from or sell into Korea a clearer route to maintain supply during disruptions. Check:

Emerging medical devices like inspiratory resistance devices such as Res-Q-Gard ITD and advanced wearable heart rate monitors help manage Postural Orthostatic Tachycardia Syndrome (POTS). They stabilize heart rate, enhance blood flow, and provide real-time symptom tracking for better daily control and improved quality of life. Check: How Can Healthcare Systems Build a Modern Procurement Strategy

Medical device marketing aligns with value-based procurement by focusing on long-term clinical outcomes, cost efficiency, and measurable return on investment. By integrating data-driven messaging, real-world evidence, and stakeholder-specific communication, marketing and sales teams can demonstrate value beyond price, helping healthcare providers make informed, outcome-focused purchasing decisions in an increasingly performance-driven procurement environment. Check: How Can

How do you choose the right medical device contract manufacturing partner in 2026? The right partner should align with your device class, regulatory roadmap, and production scale, while offering end‑to‑end services that reduce supply chain fragmentation, shorten time‑to‑market, and strengthen resilience. Prioritizing quality systems, scalability, and long‑term collaboration turns contract manufacturing from a tactical decision

In April 2026, EU MDR added new harmonized standards via Implementing Decision (EU) 2026/193 for enhanced device safety, while Japan PMDA extended ICH guidelines to generics, requiring stricter quality dossiers. These shifts extend procurement lead times by 13-18 months due to Notified Body backlogs and documentation demands. Check: How Can Healthcare Systems Build a Modern